PML-RARalpha gene detection method optimization for quantitative PCR

Otimização do método de detecção do gene PML-RARalfa para PCR quantitativo

Abstracts

Hybrid gene PML-RARalpha is the molecular target found in most cases of acute promyelocytic leukemia (APL) and has been used for diagnosis and minimal residual disease studies. The standard molecular technique employed is qualitative reverse transcriptase-polymerase chain reaction (RT-PCR), but with the emergence of real time PCR (Q-PCR), PML-RARalpha gene detection approaches have been described allowing transcript detection, with the methodological advantage of eliminating post-PCR processing. However, current protocols report the use of expensive fluorescent labeled probes, limiting its routine application in the laboratory. The objective of this study was to optimize PML-RARalpha gene detection method for Q-PCR, using SYBR® Green fluorescent dye. The analysis was performed with NB4 cellular lineage cDNA. Thermal cycling protocols, cDNA synthesis with random or specific primer and different MgCl2 and amplification primers concentrations were tested. Results show that amplification improved in the following conditions: 2 mM MgCl2, 10 pmol primers and cDNA synthesized with specific primer. There were no significant differences using annealing temperature (58°C/30 s) followed by extension (72°C/30 s) or annealing associated with extension as a single step (60°C/45 s). This paper demonstrates the optimization of PML-RARalpha gene detection for Q-PCR studies using a technique considered sensitive and less expensive for routine use in the laboratory.

APL; PML-RARalpha; Q-PCR; SYBR® Green

O gene híbrido PML-RARalfa é o marcador molecular presente na maioria dos casos de leucemia aguda promielocítica (LAP), sendo útil ao diagnóstico e ao estudo da doença residual mínima. A técnica molecular empregada como rotina laboratorial é a reação em cadeia da polimerase com transcrição reversa (RT-PCR) qualitativa, porém com o surgimento da PCR em tempo real (Q-PCR), foram descritas abordagens de detecção do gene PML-RARalfa possibilitando a quantificação de transcritos, com a vantagem metodológica da eliminação do processamento pós-PCR. No entanto, os protocolos relatam o uso de sondas fluorescentes de custo elevado para a rotina clínica, limitando sua aplicação. Este estudo teve como objetivo otimizar o método de detecção do gene PML-RARalfa para Q-PCR, utilizando como sistema de marcação fluorescente o intercalante SYBR® Green. A análise foi realizada com cDNA da linhagem celular NB4, tendo sido testados protocolos de termociclagem, síntese de cDNA com primer randômico ou específico e diferentes concentrações de MgCl2 e primers para amplificação. Os resultados mostraram amplificação mais eficiente nas seguintes condições: 2 mM MgCl2, 10 pmol de primers e cDNA sintetizado com primer específico. Não houve diferença na utilização de etapas para anelamento (58°C/30 s) seguido de extensão (72°C/30 s) ou etapa única de anelamento associado à extensão (60°C/45 s). Esses resultados demonstram a otimização da detecção do gene PML-RARalfa para Q-PCR através de um método considerado sensível e de baixo custo para a rotina laboratorial.

LAP; PML-RARalfa; Q-PCR; SYBR® Green

ORIGINAL ARTICLE ARTIGO ORIGINAL

PML-RARa gene detection method optimization for quantitative PCR

Otimização do método de detecção do gene PML-RARa para PCR quantitativo

Jaíra Ferreira de Vasconcellos^I; Raul Antônio Morais Melo^II; Fárida Coeli Barros Correia Melo^III; Washington Batista Neves^IV; Éderson Akio Kido^V

^IMD; postgraduate student in Genetics, Department of Genetics, Universidade Federal de Pernambuco (UFPE)

^IIPhD; hematologist, Department of Laboratories, Fundação Hemope; associate professor, Department of Clinical Medicine, UFPE

^IIIPharmaceutical biochemist, Department of Laboratories, Fundação Hemope; postgraduate student in Energy and Nuclear Technologies, Department of Nuclear Energy, UFPE

^IVChemist, Department of Laboratories, Fundação Hemope

^VPhD; associate professor, Department of Genetics, UFPE

^{Mailing address}

ABSTRACT

Hybrid gene PML-RARa is the molecular target found in most cases of acute promyelocytic leukemia (APL) and has been used for diagnosis and minimal residual disease studies. The standard molecular technique employed is qualitative reverse transcriptase-polymerase chain reaction (RT-PCR), but with the emergence of real time PCR (Q-PCR), PML-RARa gene detection approaches have been described allowing transcript detection, with the methodological advantage of eliminating post-PCR processing. However, current protocols report the use of expensive fluorescent labeled probes, limiting its routine application in the laboratory. The objective of this study was to optimize PML-RARa gene detection method for Q-PCR, using SYBR^® Green fluorescent dye. The analysis was performed with NB4 cellular lineage cDNA. Thermal cycling protocols, cDNA synthesis with random or specific primer and different MgCl₂ and amplification primers concentrations were tested. Results show that amplification improved in the following conditions: 2 mM MgCl₂, 10 pmol primers and cDNA synthesized with specific primer. There were no significant differences using annealing temperature (58°C/30 s) followed by extension (72°C/30 s) or annealing associated with extension as a single step (60°C/45 s). This paper demonstrates the optimization of PML-RARa gene detection for Q-PCR studies using a technique considered sensitive and less expensive for routine use in the laboratory.

key words: APL, PML-RARa, Q-PCR, SYBR^® Green

RESUMO

O gene híbrido PML-RARa é o marcador molecular presente na maioria dos casos de leucemia aguda promielocítica (LAP), sendo útil ao diagnóstico e ao estudo da doença residual mínima. A técnica molecular empregada como rotina laboratorial é a reação em cadeia da polimerase com transcrição reversa (RT-PCR) qualitativa, porém com o surgimento da PCR em tempo real (Q-PCR), foram descritas abordagens de detecção do gene PML-RARa possibilitando a quantificação de transcritos, com a vantagem metodológica da eliminação do processamento pós-PCR. No entanto, os protocolos relatam o uso de sondas fluorescentes de custo elevado para a rotina clínica, limitando sua aplicação. Este estudo teve como objetivo otimizar o método de detecção do gene PML-RARa para Q-PCR, utilizando como sistema de marcação fluorescente o intercalante SYBR^® Green. A análise foi realizada com cDNA da linhagem celular NB4, tendo sido testados protocolos de termociclagem, síntese de cDNA com primer randômico ou específico e diferentes concentrações de MgCl₂ e primers para amplificação. Os resultados mostraram amplificação mais eficiente nas seguintes condições: 2 mM MgCl₂, 10 pmol de primers e cDNA sintetizado com primer específico. Não houve diferença na utilização de etapas para anelamento (58°C/30 s) seguido de extensão (72°C/30 s) ou etapa única de anelamento associado à extensão (60°C/45 s). Esses resultados demonstram a otimização da detecção do gene PML-RARa para Q-PCR através de um método considerado sensível e de baixo custo para a rotina laboratorial.

Unitermos: LAP, PML-RARa, Q-PCR, SYBR^® Green

Introduction

Acute promyelocytic leukemia (APL) is characterized by rearrangements that include retinoic acid receptor alpha (RARa) in chromosome 17⁽⁹⁾. In almost 98% of APL cases the t(15;17)(q22;q12) is detected, involving the promyelocytic leukemia (PML) gene in chromosome 15, and generates the hybrid gene PML-RARa, the molecular target of APL^{(16, 12, 14)}.

PML-RARa fusion protein has a negative dominant function in the retinoic pathway; it is important in myeloid differentiation arrest and apoptosis inhibition, and is also involved in APL pathogenesis⁽⁸⁾.

APL cellular lineage used as a model for in vitro studies is called NB4. It was isolated from long-term leukemic blast cells culture from a patient in disease relapse⁽¹¹⁾. NB4 validation as APL cellular lineage was established by the presence of t(15;17), treatment response to all-trans retinoic acid and PML-RARa gene detection⁽¹¹⁾.

Qualitative PCR has been used for the investigation of gene rearrangements at diagnosis and for minimal residual disease studies^{(2, 19)}, but the authors have published different protocols for the quantification of PML-RARa transcripts^{(21, 4, 20, 6, 7, 18)}, employing quantitative PCR (Q-PCR) technique. Taken together, these papers have demonstrated that transcription levels can be evaluated by Q-PCR and can differentiate patients with good or poor prognosis. Nevertheless, up to now quantitative detection methods for APL have been based on expensive fluorescent labeled probes. The purpose of this study was to optimize PML-RARa gene detection method for Q-PCR, using the SYBR^® Green fluorescent dye.

Materials and methods

RNA from NB4 cell lineage was isolated by the phenol-guanidine technique⁽⁵⁾ – Trizol^® (Invitrogen, Carlsbad, CA, USA). RNA analysis was done by spectrophotometry and electrophoresis in 1.5% ethidium bromide-stained agarose gels. cDNA synthesis was performed with 1µg of RNA through reverse transcription (RT) reaction using reverse transcriptase enzyme (Gibco-BRL, Grand Island, NY, USA/Promega, Madison, WI, USA), random (New England BioLabs, Beverly, MA, USA) and specific primers, dNTP’s (Pharmacia, Piscataway, NJ, USA), water and Tris-HCl/KCl buffer. The specific primer used for RT reaction was described by van Dongen et al.⁽¹⁹⁾. After a five-minute incubation at room temperature RT conditions were: 42°C/60 min. and 70°C/15 min.

Amplification was done by the Q-PCR method⁽¹⁰⁾ using the Smart Cycler^® thermocycler (Cepheid, Sunnyvale, CA, USA). Reagents used were Taq DNA Polymerase diluted in Tris-HCl/KCl buffer with MgCl₂ (VJR, São Paulo, SP, Brazil); 10 mM dNTP’s (Pharmacia, Piscataway, NJ, USA); SYBR^® green (Molecular Probes, Eugene, OR, USA); cDNA and Milli-Q water treated with DEPC (diethylpyrocarbonate) added to a 25 µL final volume. This Milli-Q water was also used as contamination control. PML-RARa primers used were also described by van Dongen et al.⁽¹⁹⁾. The products were detected through amplification curves constructed during the reaction with the threshold set to 30. The specificity of amplified products was verified through melting curve analysis, constructed between 60°C and 95°C and with a rampage of 0.2°C/s.

Results and discussion

Two amplification protocols were tested (Table) with different MgCl₂ concentrations (2 and 3 mM) and specific primers (5, 10, 15 and 20 pmols). The first assay was tested in duplicate with different MgCl₂ concentrations (2 and 3 mM) and primers (5 and 10 pmols). The reactions with MgCl₂ 3mM had a zero cycle threshold (Ct), which means that the fluorescent signal was not sufficient to reach the threshold. With the MgCl₂ 2 mM concentration both thermocycling protocols were efficient (Cts of 29.46 and 32.2), but smaller Ct values were detected with 10 pmol primers.

Based on these results, a second assay was performed with MgCl₂ 2 mM concentration and increased primer concentrations of 15 and 20 pmols with both protocols of amplification. In this assay, Ct values had no significant difference from the latter assay. Primers and MgCl₂ were the reagents in which the concentration was analyzed. MgCl₂ concentration affects many aspects of PCR, including Taq DNA polymerase activity and primer annealing. The PCR enzyme used here (VJR, São Paulo, SP, Brazil) demonstrated high specificity with MgCl₂ 2 mM final concentration. Ideal primer concentration varies according to its sequence and amplification target. Results demonstrated no significant differences between 10, 15 and 20 pmols. Therefore, 10 pmol was selected because high primer concentrations have a limited effect on PCR and can affect the specificity of the reaction.

In the third assay, from the parameters established, the amplification efficiency from cDNA synthesized with random (0.2 µg/µL) and specific primers (5 pmols) was compared. Results demonstrated more efficient amplification from cDNA synthesized with specific primer (Ct of 24.9) than with random primers (Ct of 28.07). However, considering the relative efficiency of random primers, their use has the advantage of amplifying many genes with a single transcription reaction.

The variables selected in this study are the most important ones for an efficient Q-PCR reaction^{(13, 17, 15)}. Reverse transcription is an important step in Q-PCR. The cDNA synthesized must be representative of the sample transcripts pool⁽¹⁾. Amplicons were 381 base pair length, and annealing temperatures, 59°C and 57°C for forward and reverse primers, respectively. At first, the two amplification protocols showed similar efficiency, analyzed from Ct values, with Cts of 33.74 and 33.87.

SYBR^® Green is a sensitive but non-specific dye. It intervenes in double strand molecules and because of this property its specificity can be compromised by the formation of primer dimers or secondary structures in PCR products⁽³⁾. Thus, the specificity of the amplification reaction should be analyzed through melting curves. In this study, NB4 cellular lineage had 92°C as standard melting temperature, ensuring the specificity of amplification with SYBR^® Green.

In conclusion, PML-RARa gene detection method was optimized in the following conditions: 2mM MgCl₂, 10 pmol primers and cDNA synthesized with specific primer. The use of SYBR^® Green as fluorescent dye allowed a sensitive and less expensive laboratory analysis for diagnosis and minimal residual disease studies in APL patients.

Acknowledgments

The authors thank Prof. Dr. Eduardo Magalhães Rego (Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo [FMRP/USP]) for the NB4 cells and Dr. Vagner Augusto Benedito (Centro de Energia Nuclear na Agricultura [CENA/USP]) for the discussion of results during assays.

Primeira submissão em 17/11/06

Última submissão em 17/11/06

Aceito para publicação em 15/01/08

Publicado em 20/02/08

This study was carried out at the molecular biology laboratory of Fundação Hemope, and was supported by Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco (FACEPE). It is based on the monograph entitled "Otimização do método de detecção do gene PML-RARa para PCR quantitativo", for the specialization course in clinical analysis, Faculdade Frassinetti do Recife, in 2005. Also it was presented as a poster at Congresso Brasileiro de Hematologia e Hemoterapia, in November 2005, in Rio de Janeiro.

• 1. AERTS, J. L.; GONZALES, M. I.; TOPALIAN, S. L. Selection of appropriate control genes to assess expression of tumor antigens using real-timer RT-PCR. BioTechniques, v. 36, n. 1, p. 84-6, 88, 90-1, 2004.
• 2. BORROW, J. et al Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts. Br J Haematol, v. 82, n. 3, p. 529-40, 1992.
• 3. BUSTIN, S. A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol, v. 25, n. 2, p. 169-93, 2000.
• 4. CASSINAT, B. et al Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR. Leukemia, v. 14, n. 2, p. 324-8, 2000.
• 5. CHOMCZYNSKI, P.; SACCHI, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, v. 162, n. 1, p. 156-9, 1987.
• 6. CHOPPA, P. C. et al A novel method for the detection, quantitation, and breakpoint cluster region determination of t(15;17) fusion transcripts using a one-step real-time multiplex RT-PCR. Am J Clin Pathol, v. 119, n. 1, p. 137-44, 2003.
• 7. GALLAGHER, R. E. et al Quantitative real-time RT-PCR analysis of PML-RARa mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129. Blood, v. 101, n. 7, p. 2521-8, 2003.
• 8. GRIGNANI, F. et al The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell, v. 74, n. 3, p. 423-31, 1993.
• 9. GRIGNANI, F. et al Acute promyelocytic leukemia: from genetics to treatment. Blood, v. 83, n. 1, p. 10-25, 1994.
• 10. HIGUCHI, R. et al Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Biotechnology, v. 11, n. 9, p. 1026-30, 1993.
• 11. LANOTTE, M. et al NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood, v. 77, n. 5, p. 1080-6, 1991.
• 12. LEMONS, R. S. et al Acute promyelocytic leukemia. J Pediatr Hematol Oncol, v. 17, n. 3, p. 198-210, 1995.
• 13. LI, A. H. et al Minimal residual disease quantification in acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye. Exp Hematol, v. 30, n. 10, p. 1170-7, 2002.
• 14. MELNICK, A.; LICHT, J. D. Deconstructing a disease: RARa, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood, v. 93, n. 10, p. 3167-215, 1999.
• 15. Melo, M. R. et al Real-time PCR quantitation of glucocorticoid receptor alpha isoform. BMC Mol Biol, v. 5, n. 19, 2004. Available at: http://www.biomedcentral.com/1471-2199/5/19 Accessed on: October 26, 2006.
• 16. PANDOLFI, P. P. et al Genomic variability and alternative splicing generate multiple PML/RARa transcripts that encode aberrant PML proteins and PML/RARa isoforms in acute promyelocytic leukaemia. EMBO Journal, v. 11, n. 4, p. 1397-407, 1992.
• 17. PONCHEL, F. et al Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol, v. 3, n. 18, 2003. Available at: http://www.biomedcentral.com/1472-6750/3/18 Accessed on: October 26, 2006.
• 18. SCHNITTGER, S. et al New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFB- MYH11+ acute myeloid leukemia based on quantification of fusion transcripts. Blood, v. 102, n. 8, p. 2746-55, 2003.
• 19. van DONGEN, J. J. M. et al Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Leukemia, v. 13, n. 12, p. 1901-28, 1999.
• 20. VISANI, G. et al Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic patients: real time quantification of minimal residual disease. A pilot study. Leukemia, v. 15, n. 11, p. 1696-970, 2001.
• 21. YIN, J. A.; TOBAL, K. Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance. Br J Haematol, v. 106, n. 3, p. 578-90, 1999.

Publication Dates

• Publication in this collection
  15 May 2008
• Date of issue
  Feb 2008

History

• Reviewed
  15 Jan 2008
• Received
  17 Nov 2006
• Accepted
  20 Feb 2008